Gilead's experimental HIV treatment non-inferior to blockbuster drug in trial

Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Gilead’s experimental HIV treatment meets main goal in late-stage trial

Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...

Gilead to start demolishing buildings for campus expansion by end of month

Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google. It is the first work ...

Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors despite daily gains

The stock's rise snapped a four-day losing streak.
Fierce Pharma

Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The ...
Soap Central

The Testaments cast and characters: Every new and returning star confirmed so far in The Handmaid's Tale sequel

The series is set within the same universe as The Handmaid's Tale; however will focus on new characters as well as some ...

Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal

Gilead said its two-drug bictegravir-lenacapavir tablet was non-inferior to Biktarvy in the Phase 3 ARTISTRY-2 HIV trial.

Is Earlier Yescarta Use in Lymphoma Altering The Investment Case For Gilead Sciences (GILD)?

Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...

Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug

Arcus Biosciences (RCUS) stock falls as the company and partner Gilead (GILD) halt a Phase 3 cancer trial evaluating its anti ...
Dayton 24/7 Now

Medical helicopter called to car crash

A medical helicopter has been called to a car crash at the border between Darke and Shelby Counties.According to Shelby ...
Applied Clinical Trials Online

Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV

Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...